Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung Cancer.
Cell-derived particles in blood show promise for non-invasive lung cancer diagnosis and monitoring, pending standardization.
This expert review covers extracellular vesicle-based liquid biopsy biomarkers for NSCLC diagnosis, prognosis, and treatment monitoring, highlighting miRNA, protein, and ncRNA signatures. The review identifies key translational barriers including biological heterogeneity, lack of standardized protocols, and the need for multi-omics plus AI integration for clinical deployment.
What the study was
- Study design
- Narrative review
- Population
- NSCLC patients
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Expert Review of Molecular Diagnostics
Why it surfaced
Current-state expert review of EV liquid biopsy for NSCLC; useful background for T3/T5 pipeline context.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.